Search
2 articles for “Mast cells (MC)”
-
Anaphylaxis: Pathophysiology, Risk Factors, and Clinical Management
Abstract: Anaphylaxis is a syndrome characterized by broncho-constriction, vasodilatation, and hypovolemia, potentially fatal exposure to known or unknown antigens. It can be an immune-mediated (IgE & non-IgE) disease. Immunoglobulin G (IgG), complement related (C3a/C5a), bradykinin, leukotrienes, prostaglandin E2, and ligands of certain G-protein coupled receptors (GPCR) can directly activate mast cells, basophils, eosinophils, neutrophils, endothelial cells and smooth muscles. Serum tryptase level during episodes of anaphylaxis, skin test, and basophil activation …
Published in Research and Reviews : A Journal of Immunology · Vol. 15, Issue 2, 2025 · pp. 1–11 Read article
-
Mast Cell Activation Disorders: Diagnosis & Management
Abstract: Mast Cell Activation Disorder (MCAD) is a broad umbrella term which includes a heterogenous group of disorders characterized by the inappropriate and excessive release of mediators from mast cells. Mast Cell Activation Syndrome represents a severe and well-defined form within the broader spectrum of Mast Cell Activation Disorders. These disorders are generally divided into clonal and non-clonal categories. Clonal conditions include Systemic Mastocytosis, Cutaneous Mastocytosis, and Monoclonal Mast Cell Activation …
Published in Research and Reviews : A Journal of Immunology · Vol. 16, Issue 2, 2026 · pp. 31–40 Read article